Results 1 to 10 of about 28,987 (108)

Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China [PDF]

open access: yesHuman Vaccines and Immunotherapeutics, 2023
This study aimed to determine the willingness of college students to choose COVID-19 heterologous vaccination and its associated influencing factors in Taizhou, China. A population-based, self-administered online questionnaire was conducted from March 15
Tao-Hsin Tung   +2 more
exaly   +3 more sources

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2 [PDF]

open access: yesNature Communications, 2022
Different homologous and heterologous vaccination regimens have been used for COVID-19. Here the authors show in a cohort analysis from Catalonia that heterologous vaccination with ChAdOx1 followed by BNT162b2 has better vaccine effectiveness than two ...
Eduardo Hermosilla   +11 more
doaj   +2 more sources

Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination

open access: yesVaccines, 2023
With concerns about the efficacy of repeat annual influenza vaccination, it is important to better understand the impact of priming vaccine immunity and develop an effective vaccination strategy. Here, we determined the impact of heterologous prime-boost
Sang Moo Kang   +2 more
exaly   +3 more sources

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice [PDF]

open access: yesNature Communications, 2021
Heterologous vaccination regimens for COVID-19 could be useful for example if there is a shortage of one vaccine type. Here, Spencer et al. show that heterologous vaccination with a self-amplifying RNA vaccine and an adenoviral vectored vaccine performs ...
Alexandra J. Spencer   +15 more
doaj   +3 more sources

Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5‐included SARS‐CoV‐2 variants than homologous vaccination of mRNA vaccine [PDF]

open access: yesMedComm, 2023
BA.4 and BA.5 (BA.4/5), the subvariants of Omicron, are more transmissible than BA.1 with more robust immune evasion capability because of its unique spike protein mutations.
Dandan Peng   +22 more
doaj   +2 more sources

Hybrid immunity strategies: heterologous vaccination combined with natural SARS-CoV-2 infection [PDF]

open access: yesFrontiers in Medicine
The continuous evolution of SARS-CoV-2 poses a significant challenge to existing immune barriers, highlighting the limitations of single-modality immunization.
Yuan Huang   +7 more
doaj   +2 more sources

Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers

open access: yesVaccines, 2021
Despite limited data on safety and immunogenicity, heterologous prime-boost vaccination is currently recommended for individuals with ChAdOx1 nCoV-19 prime immunization in certain age groups.
Christian Nusshag   +2 more
exaly   +3 more sources

Heterologous prime-boost vaccination drives stromal activation and adaptive immunity against SARS-CoV-2 variants

open access: yesFrontiers in Immunology
Heterologous vaccination strategies have shown superior efficacy over homologous regimens in clinical studies, but the underlying immunological mechanisms remain incompletely understood.
Park Jong-Eun   +2 more
exaly   +3 more sources

The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China

open access: yesFrontiers in Public Health, 2022
BackgroundThere are few studies reported on the acceptance of heterologous booster vaccination for the COVID-19 vaccine among healthcare workers (HCWs) and the general population. We aimed to address that gap and explore determinant factors of acceptance
Wei Qin   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy